A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

The following is a summary of “Unconventional use of injectable long-acting cabotegravir and rilpivirine against HIV-1 in PWH ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is tapping contracting juggernaut Thermo Fisher Scientific to help meet its r | ...

The LYNX technology originated in the Traverso and Langer Laboratories at MIT, with which Lyndra has an exclusive technology ...